Recombinant CBD (Cannabidiol) antibody
Quick Overview for Recombinant CBD (Cannabidiol) antibody (ABIN7581770)
Target
Antibody Type
Reactivity
Host
Clonality
Application
Grade
Clone
-
-
Expression System
- Phage display
-
Purpose
- Mouse anti-Cannabidiol (CBD) Antibody, animal-free mAb
-
Specificity
- This is an antibody developed by antibody phage display technology using a human naive antibody gene library and Cannabidiol (CBD) peptide as antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.
-
Cross-Reactivity (Details)
- No known cross reactivity. No cross reactivtiy to THC.
-
Characteristics
- This antibody can be detected with anti-mouse Fc secondary antibodies.
-
Purification
- Protein A purification
-
Immunogen
- No immunization, animal-free antibody development. Antigen: synthetic Cannabidiol (CBD) peptide
-
Isotype
- IgG2a
-
-
-
Application Notes
- ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody Optimal working dilution should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, 0,02 % ProClin300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- CBD (Cannabidiol)
-
Background
- Cannabidiol (CBD) is a non-psychotropic phytocannabinoid which represents one of the constituents of the "phytocomplex" of Cannabis sativa. This natural compound is attracting growing interest since when CBD-based remedies and commercial products were marketed.
-
Molecular Weight
- 0.3 kDa
Target
-